Navigation Links
New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
Date:8/24/2008

PALO ALTO, Calif., Aug. 24 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) introduced its new dual wavelength X-ray diffractometer for the analysis of small molecules and proteins. The SuperNova(TM) is the first dual wavelength diffraction system to use entirely high intensity micro-source X-ray technology. It includes innovations in both X-ray technology and data analysis, enabling faster results even for the most challenging crystals.

Single crystal X-ray diffraction is used to determine the structure of small molecules and proteins at high resolution. Applications include chemistry, geology, physics, structural biology and pharmaceutical research. The trend in crystallography is towards the ability to analyze smaller, poorer crystal samples and to increase the speed of sample throughput. The significant improvement in the intensity of X-ray radiation placed on the sample from the dual Nova(TM) and Mova(TM) X-ray micro-sources makes both higher resolution and higher throughput possible.

The system is ideal for the study of challenging samples in small molecule and protein crystallography. It includes co-mounted, dual wavelength and high intensity X-ray micro-sources of both molybdenum and copper wavelength. It is the first dual wavelength system incorporating purely high intensity Mo and Cu micro-source X-ray technology.

The system improves throughput in several ways. The high intensity X-ray radiation allows for shorter X-ray exposure, as does the high sensitivity, large area Atlas CCD (charge-coupled device). Both enable faster data collection. In addition, the duty cycle (the dead time required for the CCD detector to transfer data to the computer), has been substantially reduced. As important, the AutoChem software automates crystal structure solution, refinement and report generation. Data analysis is concurrent with data collection, significantly reducing the time spent by the user to solve and refine the crystal structure.

"The SuperNova allows for high-throughput, information-rich, X-ray analysis of proteins and small molecules," said Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "This solution complements our NMR products, strengthening our strategy of giving our customers ease of use while gathering extremely detailed structural information on large numbers of samples."

For more technical information about Varian's X-ray diffraction products, please visit http://www.varianinc.com/products/

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 4,000 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site: http://www.varianinc.com.

For More Information, Contact:

Public Relations

Varian, Inc.

650.424.3845

pr@varianinc.com


'/>"/>
SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cynosure Introduces Smartlipo MPX(TM) Dual Wavelength Workstation for LaserBodySculpting(SM)
2. Siemens and Xintek Form Joint Venture to Develop Nanotechnology-Enabled Multi-Pixel X-ray Tubes
3. Faster X-ray interferometers due to single-photon interference
4. Super-resolution X-ray microscopy
5. Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals
6. Sir Walter Bodmer Joins Oxford Genome Sciences Scientific Advisory Board
7. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
8. Oxford Genome Sciences Appoints Chris Hibberd to its Board of Directors
9. Oxford Finance Corporation and GE Healthcare Financial Services Reaffirm Commitment to Biotech Sector in Europe
10. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
11. Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... June 22, 2017 , ... ... RegMedNet has produced a Spotlight series on “Cell Therapy Regulation” ... perspectives by leading experts on the unique regulatory challenges of stem cell medical ...
(Date:6/22/2017)... ... ... Charm Sciences, Inc. is pleased to announce that its Charm Amphenicol (AMPH) test ... screening test at dairies and farms for raw commingled cow milk. The test was ... system. These systems are a combination incubator and reader in one. , “The AMPH ...
(Date:6/20/2017)... , June 20, 2017  Kibow Biotech Inc., a ... announce the issuance of a new patent covering a ... by the U.S. Patent and Trademark Office on May ... of the Buzz of Bio award in 2014 in ... to developing non-drug approaches to chronic disease. Renadyl™, the ...
(Date:6/19/2017)... (PRWEB) , ... June 19, 2017 , ... ... overseeing all service activities supporting EDETEK’s products including training, implementation, support, and client ... to his new role. He has previously held leadership roles for service providers ...
Breaking Biology Technology:
(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):